Bleakley Financial Group LLC Buys 37,721 Shares of CVS Health Corporation $CVS

Bleakley Financial Group LLC lifted its stake in CVS Health Corporation (NYSE:CVS) by 140.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 64,486 shares of the pharmacy operator’s stock after acquiring an additional 37,721 shares during the quarter. Bleakley Financial Group LLC’s holdings in CVS Health were worth $4,862,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. National Pension Service boosted its stake in CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock valued at $301,532,000 after purchasing an additional 119,189 shares during the period. AE Wealth Management LLC grew its stake in shares of CVS Health by 6.2% in the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after acquiring an additional 14,983 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in CVS Health by 11.2% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after acquiring an additional 22,653 shares during the period. Alpha Omega Wealth Management LLC raised its stake in CVS Health by 12.3% in the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock worth $11,301,000 after purchasing an additional 16,418 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in CVS Health by 186.6% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock valued at $30,568,000 after purchasing an additional 258,050 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on CVS shares. Truist Financial set a $100.00 price target on shares of CVS Health in a research report on Wednesday, December 10th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Argus dropped their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Finally, Raymond James Financial increased their price objective on shares of CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Down 0.9%

CVS stock opened at $76.64 on Monday. The stock has a market capitalization of $97.50 billion, a P/E ratio of 55.53, a price-to-earnings-growth ratio of 0.80 and a beta of 0.50. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The firm has a 50-day moving average price of $78.52 and a 200-day moving average price of $76.87. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion during the quarter, compared to analysts’ expectations of $103.67 billion. During the same period in the prior year, the company earned $1.19 EPS. The firm’s quarterly revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. CVS Health’s payout ratio is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.